Alnylam ambassador, artist and AHP patient Amalia paints in her home studio. Amalia's work is featured in a new Givlaari campaign

August 25, 2022 02:24 PM EDTUpdated August 26, 10:35 AM

Marketing

Alnylam draws on patient artist’s striking depictions of life with a rare genetic disease in new ad campaign

Beth Snyder Bulik

Senior Editor

College student Amalia had just begun her freshman year when she came down with flu-like symptoms that worsened into debilitating stomach pain and eventually an …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Alnylam draws on patient artist’s striking depictions of life with a rare genetic disease in new ad campaign

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify

CMS explains what went into its first round of drug price negotiations

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra

CagriSema’s weight loss data disappointed. What does Novo do next?

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings

Al­ny­lam draws on pa­tient artist’s strik­ing de­pic­tions of life with a rare ge­net­ic dis­ease in new ad cam­paign

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

more like this

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Alnylam draws on patient artist’s striking depictions of life with a rare genetic disease in new ad campaign

Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify

CMS explains what went into its first round of drug price negotiations

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra

CagriSema’s weight loss data disappointed. What does Novo do next?

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings